Dynavax Technologies | DVAX - 贷款资金



贷款资金 更改 日
AbbVie USD 62.97B 12M 2025-09
Adma Biologics USD 69.33M 750K 2025-12
Agenus USD 169.66M 146.06M 2025-12
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
Glaxosmithkline GBP 19.82B 203.13M 2025-12
Merck USD 39.97B 6B 2025-09
Minerva Neurosciences USD 0 86.58M 2024-09
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
TG Therapeutics USD 245.64M 305K 2025-12
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03